Related Experiment Video
Updated: Aug 15, 2026

Generation and Culturing of Primary Human Keratinocytes from Adult Skin
Published on: December 22, 2017
Gene therapy for autosomal dominant disorders of keratin
Alfred S Lewin1, Peter M Glazer, Leonard M Milstone
1Department of Molecular Genetics and Microbiology, University of Florida College of Medicine, Gainesville, Florida 32610-0266, USA. lewin@ufl.edu
Abstract:
Dominant mutations that interfere with the assembly of keratin filaments cause painful and disfiguring epidermal diseases like pachyonychia congenita and epidermolysis bullosa simplex. Genetic therapies for such diseases must either suppress the production of the toxic proteins or correct the genetic defect in the chromosome. Because epidermal skin cells may be genetically modified in tissue culture or in situ, gene correction is a legitimate goal for keratin diseases. In addition, recent innovations, such as RNA interference in animals, make an RNA knockdown approach plausible in the near future. Although agents of RNA reduction (small interfering RNA, ribozymes, triplex oligonucleotides, or antisense DNA) can be delivered as nucleotides, the impermeability of the skin to large charged molecules presents a serious impediment. Using viral vectors to deliver genes for selective inhibitors of gene expression presents an attractive alternative for long-term treatment of genetic disease in the skin.
Insights
Genetic therapies for keratin diseases aim to suppress toxic protein production or correct genetic defects. Viral vectors offer a promising approach for long-term skin gene therapy, overcoming delivery challenges.
Area of Science:
- Dermatology
- Genetics
- Molecular Biology
Background:
- Dominant mutations in keratin genes cause severe epidermal diseases.
- These mutations lead to non-functional keratin filaments, resulting in skin fragility and disease.
Purpose of the Study:
- To explore genetic therapeutic strategies for keratin diseases.
- To evaluate the potential of gene correction and RNA reduction for treating these conditions.
Main Methods:
- Discusses gene correction in epidermal cells.
- Explores RNA interference (RNAi) and other RNA reduction agents.
- Highlights the challenge of skin impermeability for nucleotide delivery.
- Proposes viral vectors for delivering gene expression inhibitors.
Main Results:
- Gene correction is a viable goal for keratin diseases.
- RNA reduction strategies are becoming plausible.
- Skin impermeability poses a significant barrier to topical nucleotide delivery.
- Viral vector-mediated gene delivery is an attractive alternative.
Conclusions:
- Viral vectors offer a promising route for long-term genetic treatment of skin diseases caused by keratin mutations.
- Overcoming skin barrier challenges is crucial for effective topical gene therapy.
Related Concept Videos
Gene Therapy
Gene Therapy
Pedigree Analysis
Pleiotropy
Sex-linked Disorders
iPS Cell Differentiation
